Covid‐19 infection in psoriasis patients treated with cyclosporin

Abstract

Dermatologic TherapyVolume 33, Issue 4 e13739 Letter Covid-19 infection in psoriasis patients treated with cyclosporin Vito Di Lernia, Corresponding Author Vito Di Lernia [email protected] orcid.org/0000-0002-8961-7108 Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy Correspondence Vito Di Lernia, Dermatology Unit, Arcispedale Santa Maria Nuova, Viale Risorgimento 80, 42123 Reggio Emilia, Italy. Email: [email protected]Search for more papers by this authorMohamad Goldust, Mohamad Goldust orcid.org/0000-0002-9615-1246 Department of Dermatology, University of Rome, G. Marconi, Rome, Italy Department of Dermatology, University Hospital Basel, Basel, SwitzerlandSearch for more papers by this authorClaudio Feliciani, Claudio Feliciani orcid.org/0000-0003-0883-3210 Section of Dermatology, Department of Medicine and Surgery, University of Parma, Parma, ItalySearch for more papers by this author Vito Di Lernia, Corresponding Author Vito Di Lernia [email protected] orcid.org/0000-0002-8961-7108 Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy Correspondence Vito Di Lernia, Dermatology Unit, Arcispedale Santa Maria Nuova, Viale Risorgimento 80, 42123 Reggio Emilia, Italy. Email: [email protected]Search for more papers by this authorMohamad Goldust, Mohamad Goldust orcid.org/0000-0002-9615-1246 Department of Dermatology, University of Rome, G. Marconi, Rome, Italy Department of Dermatology, University Hospital Basel, Basel, SwitzerlandSearch for more papers by this authorClaudio Feliciani, Claudio Feliciani orcid.org/0000-0003-0883-3210 Section of Dermatology, Department of Medicine and Surgery, University of Parma, Parma, ItalySearch for more papers by this author First published: 01 June 2020 https://doi.org/10.1111/dth.13739Citations: 11Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Bragazzi NL, Riccò M, Pacifico A, et al. COVID-19 knowledge prevents biologics discontinuation: data from an Italian multi-center survey during RED-ZONE declaration. Dermatol Ther. 2020;e13508. https://doi.org/10.1111/dth.13508. PubMedWeb of Science®Google Scholar 2Conforti C, Giuffrida R, Dianzani C, di Meo N, Zalaudek I. COVID-19 and psoriasis: is it time to limit treatment with Immunosuppressants? A call for action. Dermatol Ther. 2020;e13298. https://doi.org/10.1111/dth.13298. PubMedWeb of Science®Google Scholar 3Di Lernia V. Biologics for psoriasis during COVID-19 outbreak. J Am Acad Dermatol. 2020; 82(6): e217-e218. 10.1016/j.jaad.2020.04.004 CASPubMedWeb of Science®Google Scholar 4Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012; 12(3): 180-190. 10.1038/nri3156 CASPubMedWeb of Science®Google Scholar 5Tanaka Y, Sato Y, Sasaki T. Suppression of coronavirus replication by Cyclophilin inhibitors. Viruses. 2013; 5(5): 1250-1260. 10.3390/v5051250 PubMedGoogle Scholar 6Di Lernia V, Albertini G. Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity? J Am Acad Dermatol. 2010; 63: 342-343. 10.1016/j.jaad.2009.11.593 PubMedWeb of Science®Google Scholar 7de Wilde AH, Pham U, Posthuma CC, Snijder EJ. Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology. 2018; 522: 46-55. 10.1016/j.virol.2018.06.011 PubMedWeb of Science®Google Scholar 8Di Lernia V. Antipsoriatic treatments during COVID-19 outbreak. Dermatol Ther. 2020;e13345. https://doi.org/10.1111/dth.13345. 10.1111/dth.13345 PubMedWeb of Science®Google Scholar 9Rudnicka L, Goldust M, Glowacka P, et al. Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern. J Am Acad Dermatol. 2020. https://doi.org/10.1016/j.jaad.2020.04.153. 10.1016/j.jaad.2020.04.153 Web of Science®Google Scholar Citing Literature ReferencesRelatedInformation

Topics & Concepts